SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Loading NKTR News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.62% | 78.76 | 1.2% | $808.66m | |
| SRPT | Sarepta Therapeutics, Inc. | 6.01% | 62.65 | 30.9% | $457.85m | |
| AMGN | Amgen Inc. | -1.12% | 169.71 | 1.1% | $455.78m | |
| BIIB | Biogen Inc. | -1.29% | 310.46 | 1.0% | $427.66m | |
| MDVN | Medivation, Inc. | 0.05% | 81.48 | 1.9% | $415.69m | |
| CELG | Celgene Corporation | -1.67% | 105.61 | 0.8% | $376.73m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.20% | 420.60 | 3.2% | $312.21m | |
| CPHD | Cepheid | 0.04% | 52.65 | 4.7% | $211.12m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.48% | 124.12 | 2.3% | $171.46m | |
| CLVS | Clovis Oncology, Inc. | -1.74% | 36.79 | 25.5% | $161.49m | |
| ILMN | Illumina, Inc. | 0.21% | 180.72 | 3.4% | $139.07m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.39% | 88.77 | 2.2% | $123.39m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.87% | 96.21 | 3.8% | $112.48m | |
| INCY | Incyte Corporation | 4.23% | 92.84 | 2.7% | $110.97m | |
| TSRO | TESARO, Inc. | -3.45% | 104.31 | 15.9% | $107.95m |
Company Profile
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. It provides small molecule drugs, peptides and other potential biologic drug candidates. It's drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.